You just read:

Mallinckrodt Provides Update on Phase 4 Data H.P. Acthar® Gel (Repository Corticotropin Injection) Clinical Trial in Patients with Rheumatoid Arthritis (RA)

News provided by

Mallinckrodt plc

Feb 05, 2019, 06:55 ET